Combination of Modern Radiotherapy and New Targeted Treatments for Breast Cancer Management

SIMPLE SUMMARY: Since the introduction of hormone therapy for the treatment of breast cancer (BC) three decades ago, many new targeted therapies have been developed. Some of them are currently used, such as HER2 inhibitors, while others are still under development, such as cell cycle (CDK) inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Beddok, Arnaud, Cottu, Paul, Fourquet, Alain, Kirova, Youlia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699586/
https://www.ncbi.nlm.nih.gov/pubmed/34944978
http://dx.doi.org/10.3390/cancers13246358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699586/
https://www.ncbi.nlm.nih.gov/pubmed/34944978
http://dx.doi.org/10.3390/cancers13246358

Ejemplares similares